Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study. (Q38829371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

non-alcoholic steatohepatitis

18 March 2020

main subject

steatohepatitis

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

E L Thomas

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Quentin M Anstee

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Mark Thursz

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

2

Stephen Atkinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

13

Elaine Holmes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Simon D Taylor-Robinson

14

object named as

Simon D Taylor-Robinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Jeremy F L Cobbold

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Ann Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Sann N Wai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Julie Stove

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Fariba Shojaee-Moradie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Nicola Jackson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

A Margot Umpleby

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Julie Fitzpatrick

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Jimmy D Bell

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Robert D Goldin

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Michael S Yee

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

31 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

69-77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

18 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

The role of the gut microbiota in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Rifaximin treatment in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Rifaximin pharmacology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Characterization of inflammatory bowel disease with urinary metabolic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Magnetic resonance imaging of total body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

STAMP: statistical analysis of taxonomic and functional profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

The vaginal microbiome during pregnancy and the postpartum period in a European population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Rifaximin: in vitro and in vivo antibacterial activity--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Hippurate: the natural history of a mammalian-microbial cometabolite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12904

21 January 2018

Identifiers

DOI

10.1111/HEPR.12904

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28425154%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference